Targeting female hormone receptors as cervical cancer therapy

While preventive methods for cervical cancer are effective, available therapies for advanced cervical cancers are ineffective. New experimental evidence points to weaknesses of prior studies and provides fresh molecular insights on the opposing roles of estrogen receptor alpha (ER alpha) and the progesterone receptor (PR) that may be translated into valuable treatments for a subset of cervical cancers.